CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Shares	Additional paid-in capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		143,833
Beginning balance at Dec. 31, 2023	$ 377,954	$ 1,200,218	$ 120,788	$ (730)	$ (942,322)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(2,374)
Purchases of common shares under Share Repurchase Plan	(13,370)	$ (13,370)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		2,231
Issuance of common shares from exercise of stock options and vesting of RSUs	28	$ 21,134	(21,106)
Shared-based compensation	5,737		5,737
Unrealized gain (loss) on available-for-sale securities	(124)			(124)
Net income	(10,749)				(10,749)
Ending balance (in shares) at Mar. 31, 2024		143,690
Ending balance at Mar. 31, 2024	359,476	$ 1,207,982	105,419	(854)	(953,071)
Beginning balance (in shares) at Dec. 31, 2023		143,833
Beginning balance at Dec. 31, 2023	377,954	$ 1,200,218	120,788	(730)	(942,322)
Increase (Decrease) in Stockholders' Equity
Net income	4,323
Ending balance (in shares) at Sep. 30, 2024		143,109
Ending balance at Sep. 30, 2024	388,002	$ 1,206,613	119,773	(385)	(937,999)
Beginning balance (in shares) at Mar. 31, 2024		143,690
Beginning balance at Mar. 31, 2024	359,476	$ 1,207,982	105,419	(854)	(953,071)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(1,050)
Purchases of common shares under Share Repurchase Plan	(5,249)	$ (5,249)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		192
Issuance of common shares from exercise of stock options and vesting of RSUs	383	$ 1,773	(1,390)
Issuance of common shares under ESPP (in shares)		152
Issuance of common shares under ESPP	703	$ 1,048	(345)
Shared-based compensation	8,586		8,586
Unrealized gain (loss) on available-for-sale securities	(5)			(5)
Net income	722				722
Ending balance (in shares) at Jun. 30, 2024		142,984
Ending balance at Jun. 30, 2024	364,616	$ 1,205,554	112,270	(859)	(952,349)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		125
Issuance of common shares from exercise of stock options and vesting of RSUs	235	$ 1,059	(824)
Shared-based compensation	8,327		8,327
Unrealized gain (loss) on available-for-sale securities	474			474
Net income	14,350				14,350
Ending balance (in shares) at Sep. 30, 2024		143,109
Ending balance at Sep. 30, 2024	$ 388,002	$ 1,206,613	119,773	(385)	(937,999)
Beginning balance (in shares) at Dec. 31, 2024	140,883	140,883
Beginning balance at Dec. 31, 2024	$ 377,478	$ 1,187,696	126,999	(647)	(936,570)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(5,807)
Purchases of common shares under Share Repurchase Plan	(47,400)	$ (47,400)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		2,671
Issuance of common shares from exercise of stock options and vesting of RSUs	355	$ 22,966	(22,611)
Shared-based compensation	(3,409)		(3,409)
Unrealized gain (loss) on available-for-sale securities	(178)			(178)
Net income	23,344				23,344
Ending balance (in shares) at Mar. 31, 2025		137,747
Ending balance at Mar. 31, 2025	$ 350,190	$ 1,163,262	100,979	(825)	(913,226)
Beginning balance (in shares) at Dec. 31, 2024	140,883	140,883
Beginning balance at Dec. 31, 2024	$ 377,478	$ 1,187,696	126,999	(647)	(936,570)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)	441
Net income	$ 76,408
Ending balance (in shares) at Sep. 30, 2025	131,841	131,841
Ending balance at Sep. 30, 2025	$ 365,771	$ 1,116,797	109,885	(749)	(860,162)
Beginning balance (in shares) at Mar. 31, 2025		137,747
Beginning balance at Mar. 31, 2025	350,190	$ 1,163,262	100,979	(825)	(913,226)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(5,352)
Purchases of common shares under Share Repurchase Plan	(43,362)	$ (43,362)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		190
Issuance of common shares from exercise of stock options and vesting of RSUs	1,199	$ 2,062	(863)
Issuance of common shares under ESPP (in shares)		83
Issuance of common shares under ESPP	401	$ 620	(219)
Shared-based compensation	5,440		5,440
Unrealized gain (loss) on available-for-sale securities	(80)			(80)
Net income	21,513				21,513
Ending balance (in shares) at Jun. 30, 2025		132,668
Ending balance at Jun. 30, 2025	335,301	$ 1,122,582	105,337	(905)	(891,713)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(1,090)
Purchases of common shares under Share Repurchase Plan	(8,785)	$ (8,785)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		263
Issuance of common shares from exercise of stock options and vesting of RSUs	1,629	$ 3,000	(1,371)
Shared-based compensation	5,919		5,919
Unrealized gain (loss) on available-for-sale securities	156			156
Net income	$ 31,551				31,551
Ending balance (in shares) at Sep. 30, 2025	131,841	131,841
Ending balance at Sep. 30, 2025	$ 365,771	$ 1,116,797	$ 109,885	$ (749)	$ (860,162)